SZSE:000999 (China)
Â
Class A
Â¥
45.11
(+0.13%)
Nov 29
Business Description
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
NAICS : 325199
SIC : 2834
ISIN : CNE0000011K8
Share Class Description:
SZSE:000999: Class ACompare
Compare
Traded in other countries / regions
000999.China IPO Date
2000-03-09Description
China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.29 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | 0.59 | |||||
| Interest Coverage | 55.87 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.38 | |||||
| Beneish M-Score | -2.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21.8 | |||||
| 3-Year EBITDA Growth Rate | 23.3 | |||||
| 3-Year EPS without NRI Growth Rate | 26.6 | |||||
| 3-Year FCF Growth Rate | 27.5 | |||||
| 3-Year Book Growth Rate | 11.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 18.1 | |||||
| Future 3-5Y Total Revenue Growth Rate | 11.21 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.11 | |||||
| 9-Day RSI | 41.23 | |||||
| 14-Day RSI | 46.01 | |||||
| 6-1 Month Momentum % | -2.87 | |||||
| 12-1 Month Momentum % | 25.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.88 | |||||
| Quick Ratio | 1.47 | |||||
| Cash Ratio | 0.72 | |||||
| Days Inventory | 153.09 | |||||
| Days Sales Outstanding | 88.89 | |||||
| Days Payable | 93.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.26 | |||||
| Dividend Payout Ratio | 0.52 | |||||
| 3-Year Dividend Growth Rate | 32.4 | |||||
| Forward Dividend Yield % | 5.43 | |||||
| 5-Year Yield-on-Cost % | 8.21 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 1.93 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.86 | |||||
| Operating Margin % | 18.17 | |||||
| Net Margin % | 13.18 | |||||
| FCF Margin % | 13.82 | |||||
| ROE % | 17.35 | |||||
| ROA % | 8.46 | |||||
| ROIC % | 17.34 | |||||
| ROC (Joel Greenblatt) % | 60.93 | |||||
| ROCE % | 16.42 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.89 | |||||
| Forward PE Ratio | 14.52 | |||||
| PE Ratio without NRI | 15.53 | |||||
| Shiller PE Ratio | 28.02 | |||||
| Price-to-Owner-Earnings | 20.71 | |||||
| PEG Ratio | 1.09 | |||||
| PS Ratio | 2.15 | |||||
| PB Ratio | 2.82 | |||||
| Price-to-Tangible-Book | 5.1 | |||||
| Price-to-Free-Cash-Flow | 15.72 | |||||
| Price-to-Operating-Cash-Flow | 12.94 | |||||
| EV-to-EBIT | 11.59 | |||||
| EV-to-Forward-EBIT | 8.16 | |||||
| EV-to-EBITDA | 11.59 | |||||
| EV-to-Forward-EBITDA | 7.41 | |||||
| EV-to-Revenue | 2.05 | |||||
| EV-to-Forward-Revenue | 1.39 | |||||
| EV-to-FCF | 15.37 | |||||
| Price-to-Projected-FCF | 1.23 | |||||
| Price-to-DCF (Earnings Based) | 1.05 | |||||
| Price-to-DCF (FCF Based) | 1.01 | |||||
| Price-to-Median-PS-Value | 0.96 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.89 | |||||
| Price-to-Graham-Number | 1.88 | |||||
| Price-to-Net-Current-Asset-Value | 19.87 | |||||
| Earnings Yield (Greenblatt) % | 8.63 | |||||
| FCF Yield % | 6.01 | |||||
| Forward Rate of Return (Yacktman) % | 20.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 25,871.244 | ||
| EPS (TTM) (Â¥) | 2.671 | ||
| Beta | 0.36 | ||
| Volatility % | 24.84 | ||
| 14-Day RSI | 46.01 | ||
| 14-Day ATR (Â¥) | 1.598961 | ||
| 20-Day SMA (Â¥) | 47.2775 | ||
| 12-1 Month Momentum % | 25.15 | ||
| 52-Week Range (Â¥) | 36.24 - 52.55 | ||
| Shares Outstanding (Mil) | 1,284.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Frequently Asked Questions
What is China Resources Sanjiu Medical & Pharmaceutical Co Ltd(SZSE:000999)'s stock price today?
The current price of SZSE:000999 is ¥45.11. The 52 week high of SZSE:000999 is ¥52.55 and 52 week low is ¥36.24.
When is next earnings date of China Resources Sanjiu Medical & Pharmaceutical Co Ltd(SZSE:000999)?
The next earnings date of China Resources Sanjiu Medical & Pharmaceutical Co Ltd(SZSE:000999) is .
Does China Resources Sanjiu Medical & Pharmaceutical Co Ltd(SZSE:000999) pay dividends? If so, how much?
The Dividend Yield %  of China Resources Sanjiu Medical & Pharmaceutical Co Ltd(SZSE:000999) is 3.26% (As of Today), Highest Dividend Payout Ratio of China Resources Sanjiu Medical & Pharmaceutical Co Ltd(SZSE:000999) was 0.52. The lowest was 0.12. And the median was 0.32. The  Forward Dividend Yield % of China Resources Sanjiu Medical & Pharmaceutical Co Ltd(SZSE:000999) is 5.43%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers